Showing results (321-330 of 349) with videos related to
Sort By:
Pageof 35
Biosensors & Bioelectronics|May 31, 2024
Monolayer, open-mesh, pristine PEDOT:PSS-based conformal brain implants for fully MRI-compatible neural interfacesJung-Hoon Hong, Ju Young Lee, Ankan Dutta, et al.Cell Reports. Medicine|May 14, 2024
IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapyKun-Joo Lee, Donghoon Choi, Nara Tae, et al.Journal of the American College of Cardiology|March 17, 2018
Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO TrialPil Hyung Lee, Jae-Kwan Song, Jong S Kim, et al.Clinical Hypertension|May 25, 2026
Highlights of the 2026 Korean Society of Hypertension guidelines for the management of hypertension: what's new and what has changedEun Mi Lee, In-Jeong Cho, Hee-Taik Kang, et al.Heart (British Cardiac Society)|February 3, 2022
Inter-racial differences in patients undergoing transcatheter aortic valve implantationDo-Yoon Kang, Jung-Min Ahn, Juyong Brian Kim, et al.JACC. Cardiovascular Interventions|November 28, 2021
Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve ReplacementHanbit Park, Jung-Min Ahn, Do-Yoon Kang, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.Clinical Therapeutics|February 11, 2026
Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical TrialSang Hyun Lee, Kyungil Park, Ki Hong Lee, et al.Korean Circulation Journal|November 22, 2012
Transcatheter aortic valve implantation: early experience in KoreaWon-Jang Kim, Young-Hak Kim, Jong-Young Lee, et al.Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.Pageof 35